Olema Pharmaceuticals, Inc. OLMA Other Assets And Long Term Deposits Non Current
Other Assets And Long Term Deposits Non Current at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept olma:OtherAssetsAndLongTermDepositsNonCurrent.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current?
- Olema Pharmaceuticals, Inc. (OLMA) reported other assets and long term deposits non current of $16.5M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current changed year-over-year?
- Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current increased by 38.4% year-over-year, from $11.92M to $16.5M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s other assets and long term deposits non current has grown at a 58.2% compound annual growth rate (CAGR), from $4.25M to $16.83M.
- What does other assets and long term deposits non current mean?
- This metric represents the aggregate value of long-term assets and deposits that do not fall into standard categories like property, plant, equipment, or intangible assets. For a clinical-stage biopharmaceutical company, these often include long-term security deposits for leased laboratory or office facilities and other non-current financial instruments. Monitoring this balance helps investors understand the company's long-term capital commitment to non-operating infrastructure.